Anything to declare? Border stories on the conflict of interest

On September 15, 2001, a joint editorial simultaneously published in thirteen medical journals, pointed an accusing finger at the increasing pressures coming from the pharmaceutical industry. During past decades, a key role in trial design and conduct was played by independent clinical investigators working in academic medical centres. They were also able to vouchsafe the quality of their research, which might not, however, be the case in the future.